Handelsavisen
prelaunch
08
082270.KQ KOE Semiconductors

GemVax & KAEL Co Ltd

$12 910,00
Open in Charts → Attach watcher ⌖
KRW
Set alert
Last 30 days
1D5D1M3M6MYTD1Y5YMax
Live price chart loads from the market-data widget.
Mcap
546,9B KRW
P/E
EV / Rev
Div yield
Op margin
3,0 %
ROE
-19,8 %
Net margin
-13,9 %
Debt / equity
1,01
Beta
52w range
Volume
Day range
Prev close
Open
Next earnings
Ex-dividend
TR 1Y
About

GemVax & KAEL Co Ltd designs and manufactures semiconductor components for the technology equipment industry.

Business. GemVax & KAEL Co Ltd (082270.KQ) is a technology equipment company operating in the semiconductors industry. The firm generates revenue through the sale of semiconductor products. Specific details regarding operating segments, headquarters location, and primary stock exchange listings are not available in the provided data.

Classification92 %
SectorTechnology
Business sectorTechnology Equipment
IndustrySemiconductors
Generated · model-assisted
Sell-side consensus
consensus pending
— buy— hold— sell
Avg 12m price target
Upcoming events
— missing data
See all catalysts →

At a glance

Score
36
composite score
Valuation
valuation pending
Analysts
not yet wired
Ownership
not yet wired
Profitability
-19,8 %
return on equity
Quality
58
quality score (0-100)

News & coverage

0
  • No recent newsroom coverage mentioning 082270.
  • Sector rotation

    Sector1D1Mvs mkt
    Materials+2,1 %+0,7 %+2,5 %
    Energy+1,1 %+5,5 %+1,5 %
    Health Care+0,6 %−0,4 %+1,0 %
    Consumer Discretionary+0,4 %+5,7 %+0,8 %
    Information Technology · THIS SECTOR−0,3 %+4,8 %+0,1 %
    Financials−0,5 %−3,5 %−0,1 %
    Real Estate−0,7 %+10,8 %−0,3 %
    Consumer Staples−0,8 %+4,5 %−0,4 %
    Utilities−1,5 %−21,2 %−1,1 %
    Industrials−1,7 %−2,4 %−1,3 %
    Communication Services

    Developing storylines

    No tracked sagas currently linked to 082270.KQ. Browse all sagas →

    Analysis

    AI analysis
    Generated · analysis pipeline · tier hybrid · as of 2026-06-25 ↑ At a glance

    Opportunity

    — missing data

    Upcoming catalysts

    Scheduled public events. Informational only — not investment advice.

    • Macro
    • Rate decisionSveriges Riksbank rate decision (press conf.)2026-06-25 · SE
    • Rate decisionReserve Bank of Australia rate decision (press conf.)2026-07-08 · AU
    • Rate decisionBank of Canada rate decision (press conf.)2026-07-15 · CA
    • Rate decisionEuropean Central Bank rate decision (press conf.)2026-07-16 · EU
    • Rate decisionBank of Japan rate decision (press conf.)2026-07-16 · JP
    • Rate decisionFederal Reserve rate decision (press conf.)2026-07-29 · US
    • Macro & political
    • ElectionSE Swedish Election2026-09-14 · SE
    • ElectionUS U.S. Midterms2026-11-03 · US
    • ElectionFR French Legislative2027-06-01 · FR

    Pre-earnings brief

    — missing data

    Signals & dispatch

    peak dispatch · —

    Composite-score breakdown

    Composite score36 / 100
    Composite score 0-100 · Data quality 0,58
    Data quality0,58 / 1.00

    Synthesis

    Business

    GemVax & KAEL Co Ltd (082270.KQ) is a technology equipment company operating in the semiconductors industry. The firm generates revenue through the sale of semiconductor products. Specific details regarding operating segments, headquarters location, and primary stock exchange listings are not available in the provided data.

    Classification92 %
    SectorTechnology
    Business sectorTechnology Equipment
    IndustrySemiconductors
    AI synthesis
    GENERATED

    The company's capital structure shows a price-to-book ratio of 12.53 and a debt-to-equity ratio of 1.01, indicating a leveraged but not highly indebted position relative to equity. With cash and equivalents of 17,577.87 billion KRW and long-term debt of 58,070.71 billion KRW, the firm has negative net cash, which raises liquidity concerns. The current ratio of 0.66 suggests short-term liquidity is strained, as current liabilities exceed current assets.

    Profitability metrics show significant underperformance relative to industry norms. The company reported a net loss of 11,336.64 billion KRW and an operating income of 2,471.24 billion KRW, resulting in a return on equity of -19.81% and return on assets of -7.14%. These figures are well below the typical performance of semiconductor firms, which usually maintain positive ROE and ROA in the 10-20% range.

    The company's revenue is concentrated in a single business segment, with no disclosed geographic diversification in the provided data. This lack of segment and geographic diversification increases exposure to sector-specific and regional risks.

    Growth trajectory appears negative, with the company reporting a net loss in the latest period and free cash flow of -8,025.04 billion KRW. Analyst estimates for revenue and EPS also show a continuation of this trend, with last actual revenue at 65,663.22 billion KRW and EPS at -162.00 KRW. The outlook for the next fiscal year is not provided, but the current performance suggests a challenging path to growth.

    Risk factors include medium liquidity risk due to the negative net cash position and a current ratio below 1. Dilution risk is assessed as low, with no significant changes in shares outstanding between basic and diluted shares. However, the company's negative net income and free cash flow could pressure the balance sheet and increase reliance on external financing in the future.

    Recent financial filings show a deteriorating operating cash flow of 1,108.49 billion KRW and a capital expenditure of -997.19 billion KRW. No recent earnings call transcripts or major announcements are available in the provided data, but the financial snapshot indicates operational challenges that may require closer monitoring.

    Key takeaways
    • The company is significantly underperforming in profitability with a negative ROE of -19.81% and ROA of -7.14%.
    • Liquidity is strained with a current ratio of 0.66 and negative net cash position.
    • Revenue is concentrated in a single business segment with no geographic diversification disclosed.
    • Free cash flow is negative at -8,025.04 billion KRW, indicating operational cash generation challenges.
    • The company's capital structure is leveraged with a debt-to-equity ratio of 1.01.

    Bull / Bear case

    Generated · model-assisted
    — missing data

    In focus — financials by report

    Valuation

    Market price
    $12 910,00
    Market cap
    $716.83B
    Enterprise value
    $757.33B
    P/E
    Non-GAAP P/E
    EV / Revenue
    EV / Op income
    EV / OCF
    683.2x
    P / B
    12.5x
    P / Tangible book
    12.5x
    Tangible book
    $57.23B
    Net cash
    -$40.49B
    Current ratio
    0.7
    Debt / equity
    1.0
    ROA
    -7.1%
    ROE
    -19.8%
    Cash conversion
    -10.0%
    CapEx / revenue
    -1.2%
    SBC / revenue
    Dilution ratio
    0.0%

    Revenue by segment

    Market share

    — missing data

    Business relationships

    — missing data

    Supply chain

    — missing data

    Peer comparison

    — missing data

    Market position

    Stress test

    — missing data

    Forward curve

    — missing data

    Options

    — missing data

    Short squeeze

    — missing data

    Earnings-call key lines

    — missing data

    Estimate revisions

    consensus EPS · 26-week trend
    — missing data

    Sell-side observations

    — missing data

    Themes

    — missing data

    ESG

    — missing data

    Risk factors

    — missing data

    Benchmarks vs cohort

    Op Margin3,0 %Above median
    Net Margin-13,9 %Bottom quartile
    ROE-19,8 %Bottom quartile
    Capex / Rev-1,2 %Above P75
    D/E1,01Bottom quartile
    Cash Conv-0,10Below median

    Corporate actions / M&A

    — missing data

    FX exposure

    — missing data

    Comparable transactions

    — missing data

    Derivatives & instruments

    — missing data

    Actions

    Ask Handelsavisen

    — missing data
    Data sources
    • Market data
    • Market data cache
    • Issuer disclosures
    • Public news
    • Earnings transcripts
    • Consensus estimates
    • ESG data
    How metrics are computed
    • Ev To Operating Cash Flow
      enterprise_value / operating_cash_flow
    • Return On Equity
      net_income / total_equity
    • Price To Book
      market_price / (adjusted_book_value / shares_outstanding_diluted)
    • Dilution Ratio
      (shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
    • Market Price
      input from market-data provider (delayed close or quote-shim mid)
    • Market Cap
      market_price * shares_outstanding_diluted
    Source documents
    • GemVax & KAEL Co Ltd Market data — financials · 2026-05-26
    • GemVax & KAEL Co Ltd Market data — analyst estimates · 2026-05-26

    Ownership & reference

    Insider activity

    — missing data

    Geographic breakdown

    — missing data
    Listings · one canonical issuer all listings resolve to the canonical
    082270.KQCanonical
    KOE · KRW

    Intel & risk

    peak dispatch · —
    OSINT findings
    Dilution riskLow
    Liquidity riskMedium
    Net cash is negative after subtracting total debt.
    Relationship graph
    082270NVDAINTCAVGOSemiconductors
    This companyPeerSector

    The Thread

    Everything we know, in order
    — missing data
    Sources filings · IR · transcripts · market data · tier hybrid · as of 2026-06-25 Market data · Issuer disclosures · Public news · Earnings transcripts · Consensus estimates · ESG data Premium coverage